Sodium Hydroxide → 2-(1-(Tert-butoxycarbonyl)-3-(4-fluorophenyl)-5-oxo-8,11-dioxa-1,4-diazaspiro[5.6]dodecan-4-yl)ethanoic acid
反応式
[OH-].[Na+].[F:3][C:4]1[CH:9]=[CH:8][C:7]([CH:10]2[N:15]([CH2:16][C:17]([O:19]C)=[O:18])[C:14](=[O:21])[C:13]3([CH2:27][O:26][CH2:25][CH2:24][O:23][CH2:22]3)[N:12]([C:28]([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])=[O:29])[CH2:11]2)=[CH:6][CH:5]=1>CO>[C:31]([O:30][C:28]([N:12]1[C:13]2([CH2:27][O:26][CH2:25][CH2:24][O:23][CH2:22]2)[C:14](=[O:21])[N:15]([CH2:16][C:17]([OH:19])=[O:18])[CH:10]([C:7]2[CH:6]=[CH:5][C:4]([F:3])=[CH:9][CH:8]=2)[CH2:11]1)=[O:29])([CH3:34])([CH3:32])[CH3:33]参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
2.0 ml (2.0 mmol) of a 1N aqueous sodium hydroxide solution were added to 0.29 mg (0.61 mmol) tert-butyl 3-(4-fluorophenyl)-4-(2-methoxy-2-oxoethyl)-5-oxo-8,11-dioxa-1,4-diazaspiro[5.6]dodecane-1-carboxylate in 5 ml MeOH. After 1 h at RT MeOH was distilled off and the aqueous solution was acidified with 1N hydrochloric acid. The aqueous phase was extracted with ethyl acetate. The ethyl acetate phase was dried and evaporated down.
後処理
- distillationAfter 1 h at RT MeOH was distilled off
- extractionThe aqueous phase was extracted with ethyl acetate
- dry with materialThe ethyl acetate phase was dried
- customevaporated down
出典と根拠
- ORDレコード
- ord-691fccf8d85746ff902c488daf28e7df
- 出典データセット
- uspto-grants-2014_07
- 特許番号
- US08765763B2
反応ノート
読み込み中…